SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Three Amigos Stock Thread

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Magnatizer who wrote (4242)5/3/1998 3:16:00 PM
From: Tummus1  Read Replies (3) of 29382
 
To All:
I know you folks aren't really momentum players but if you are interested, you may wish to keep an eye on ENMD. The NYT and other news papers are giving them front page press as having a "cancer cure". That ultimatly will be too simplistic however, they are the real thing. Based on Judah Folkman's remarkable work at Harvard Medical School, ENMD has developed drugs which inhibit the development of blood flow into tumors in mice. It really works, and Richard Klausner, director of the National Cancer Institute, said that he is giving these drugs top priority.
Downside is that the valuation of biotech stocks can get wacky and ENMD's will probably get wackier tommorow. This news on ENMD is really old news but with major press hype, so I don't know if it will run 30% or 300% next week. For all I know, it may sell on news. If it really goes beserk it might be a good short. Also there are other companies working on similar technology. They might be worth watching as sympathy plays. I forget who they are but will dig them up and post later.
This is not a buy rec. but just a heads up. I won't chase it tomorrow unless the volume starts screaming at me.
TW

PS Drinking KKKAAAAVVVAA as I write this.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext